In a child with a non‑painful, itchy rash (not petechial or purpuric) that improved after antihistamine, and isolated arch foot pain more pronounced on the left, what is the most likely diagnosis and how should it be managed?

Diagnosis: Atopic Dermatitis (Eczema)

Based on the clinical presentation—a non-painful, itchy rash that responded to antihistamines, without petechiae or purpura, combined with isolated arch foot pain—the most likely diagnosis is atopic dermatitis with concurrent foot pain from an unrelated mechanical cause rather than a systemic inflammatory condition.

The absence of petechiae or purpura effectively rules out vasculitic processes (including Henoch-Schönlein purpura), which would typically present with palpable purpura and systemic involvement 1. The rash characteristics and response to antihistamines align with atopic eczema rather than urticarial vasculitis, where individual weals would persist for days rather than hours 2.

Clinical Reasoning

Why Atopic Dermatitis is Most Likely:

• Itchy, non-painful rash: Atopic eczema presents as an itchy skin condition, which is the cardinal feature required for diagnosis 1
• Response to antihistamines: While antihistamines have limited efficacy in atopic dermatitis itself, their sedative properties can reduce scratching and provide symptomatic relief during acute flares 1
• Absence of petechiae/purpura: This excludes vasculitic processes and immunodeficiency states, which should be considered when petechiae are present 1

The Foot Pain Component:

The isolated bilateral arch pain (left > right) is most likely unrelated to the rash and represents a mechanical issue such as plantar fasciitis or overuse, rather than a systemic inflammatory arthropathy. If this were part of a systemic vasculitic process, you would expect:

• Purpuric rash (which is explicitly absent)
• Joint swelling rather than isolated arch pain
• Constitutional symptoms 1

Management Algorithm

Immediate Management:

1. Confirm Diagnosis Through History:

• Duration of rash and whether it's been present >6 weeks (chronic) or <6 weeks (acute) 1
• Distribution: Look specifically for flexural involvement (elbows, neck) or cheeks in younger children 1
• Personal or family history of atopy (asthma, hay fever, allergic rhinitis) 1
• History of general dry skin in the past year 1
• Aggravating factors: exposure to soaps, detergents, woolen clothing, temperature extremes 1

2. Physical Examination Focus:

• Document extent, location, and severity of eczema 1
• Look for crusting or weeping suggesting secondary bacterial infection with Staphylococcus aureus 1
• Check for grouped vesicles or punched-out erosions indicating herpes simplex superinfection 1
• Examine nails (should be short to minimize scratching damage) 1

First-Line Treatment Protocol:

1. Discontinue Antihistamines for Maintenance:

• Antihistamines have therapeutic value primarily through sedative properties, not direct anti-itch effects in atopic dermatitis 1
• Non-sedating antihistamines have little to no value in atopic eczema 1
• Reserve sedating antihistamines only for short-term use during severe pruritus flares, administered at night to avoid daytime sedation 1
• Large doses may be required in children 1

2. Implement Skin Care Regimen:

• Avoid all soaps and detergents: Use dispersible cream as soap substitute for cleansing 1
• Bathing protocol: Allow patient/family to choose preferred bath oil; bathing is useful for cleansing and hydrating 1
• Liberal emollient use: Apply after bathing to provide surface lipid film that retards evaporative water loss 1
• Cotton clothing only: Avoid woolen or irritant fabrics next to skin 1
• Temperature control: Avoid extremes of temperature 1

3. Topical Corticosteroids (Mainstay of Treatment):

• Use the least potent preparation required to control eczema 1
• Apply no more than twice daily (some newer preparations require only once daily) 1
• Stop for short periods when possible to minimize side effects 1
• Consider potency based on: patient age, site to be treated, and disease extent 1
• Critical counseling point: Address steroid phobia directly, as undertreatment from fear of steroids is common 1

4. Alternative Topical Agents:

• Ichthammol or coal tar: 1% ichthammol in zinc ointment or coal tar solution (1% strength) for lichenified areas 1
• These do not cause systemic absorption issues unless used extravagantly 1

Management of Secondary Infection (If Present):

If crusting or weeping is present:

• Send bacteriological swabs for S. aureus 1
• Flucloxacillin is first-line for S. aureus (most common pathogen) 1
• Phenoxymethylpenicillin if β-hemolytic streptococci isolated 1
• Erythromycin for flucloxacillin resistance or penicillin allergy 1

If grouped vesicles/erosions suggest herpes simplex:

• Oral acyclovir given early in disease course 1
• IV acyclovir if patient is ill or febrile 1

Addressing the Foot Pain:

Since the foot pain is isolated to the arches bilaterally without systemic features:

• Evaluate for mechanical causes (plantar fasciitis, inappropriate footwear, overuse)
• Consider orthotic assessment if pain persists
• This is not part of the dermatological diagnosis given the absence of purpura and systemic features

Common Pitfalls to Avoid:

1. Over-relying on antihistamines: They do not treat the underlying eczema and have minimal anti-pruritic effect in atopic dermatitis 1, 3, 4

2. Steroid phobia leading to undertreatment: Lack of adherence often traces back to fears about steroids; education is essential 1

3. Assuming foot pain is related to rash: Without purpura, systemic symptoms, or joint swelling, the arch pain is likely mechanical rather than inflammatory 1

4. Missing secondary infection: Deterioration in previously stable eczema may indicate bacterial or viral superinfection requiring specific treatment 1

5. Inadequate emollient quantities: Emollients should be prescribed in adequate amounts and used liberally 1

When to Refer:

Refer to dermatology if 1:

• Failure to respond to first-line treatment measures
• Diagnostic uncertainty
• Severe or extensive disease requiring second-line therapies